Crossmark Global Holdings Reduces Stake in Humana

Insurance provider's shares sold during third quarter

Published on Mar. 9, 2026

Crossmark Global Holdings Inc. reduced its stake in Humana Inc. (NYSE:HUM) by 63.2% during the third quarter, according to a recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,055 shares of the insurance provider's stock after selling 13,829 shares during the period.

Why it matters

This filing provides insight into the investment strategy and portfolio changes of Crossmark Global Holdings, a notable institutional investor. The reduction in Humana shares could signal a shift in the firm's outlook on the insurance company's performance or valuation.

The details

Crossmark Global Holdings sold 13,829 shares of Humana stock during the third quarter, reducing its total holdings to 8,055 shares. The firm's position in Humana was valued at $2,096,000 at the end of the reporting period.

  • Crossmark Global Holdings reduced its Humana stake during the third quarter of the year.

The players

Crossmark Global Holdings Inc.

An institutional investment firm that manages a portfolio of equity and fixed-income securities.

Humana Inc.

A major health insurance provider headquartered in Louisville, Kentucky, offering Medicare Advantage plans, prescription drug coverage, and commercial group health plans.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing shifts in institutional investment strategies and portfolio compositions, which can provide valuable insights into market trends and the perceived outlook for specific companies like Humana.